Author:
Viens P,Palangié T,Janvier M,Fabbro M,Roché H,Delozier T,Labat J P,Linassier C,Audhuy B,Feuilhade F,Costa B,Delva R,Cure H,Rousseau F,Guillot A,Mousseau M,Ferrero J M,Bardou V J,Jacquemier J,Pouillart P
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Antman, K, Gale, RP (1988). Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. Ann Intern Med 108: 570–574.
2. Armstrong, DK, Fetting, JH, Davidson, NE, Gordon, GB, Huelskamp, AM & Abeloff, MD (1993). Sixteen-week dose intense chemotherapy for inoperable, locally advanced breast cancer. Breast Cancer Res Treat 28: 277–284.
3. Basser, RL, To, LB, Begley, CG, Juttner, CA, Maher, DW, Szer, J, Cebon, J, Russel, I, Olver, I, Gill, PG, Fox, RM, Sheridan, WP & Green, MD (1995). Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. Clin Cancer Res 1: 715–721.
4. Bauer, RL, Busch, E, Levine, E & Edge, SB (1995). Therapy for inflammatory breast cancer: impact of doxorubicin-based therapy. Ann Surg Oncol 2: 288–294.
5. Bezwoda, WR, Seymour, L & Dansey, RD (1995). High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol 13: 2483–2489.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献